Acute Effects of Added Sugar Intake on Cerebrovascular Function and Brain Integrity
NCT ID: NCT05408338
Last Updated: 2023-05-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2022-06-14
2023-04-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Added Sugar Intake on Brain Blood Flow and Hippocampal Function in Midlife Adults
NCT05211726
Brain Healthy Soul Food Diet Intervention Among Older African Americans
NCT05414682
Health Effects of Grain Foods in Adults
NCT06339879
The Impact of Reformulated Foods on Cardiovascular Risk Factors
NCT01645995
Carb Quality and CHD in US Adults
NCT03214861
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low Added Sugar Meal
Participants will be provided a meal low in added sugars.
Low Added Sugar Meal
Consumption of a single 1,250 kcal meal containing 16 g of added sugars (5% of total energy)
High Added Sugar Meal
Participants will be provided a meal high in added sugars.
High Added Sugar Meal
Consumption of a single 1,250 kcal meal containing 61 g of added sugars (20% of total energy)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low Added Sugar Meal
Consumption of a single 1,250 kcal meal containing 16 g of added sugars (5% of total energy)
High Added Sugar Meal
Consumption of a single 1,250 kcal meal containing 61 g of added sugars (20% of total energy)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men and women within the ages of 30-64 years;
* Habitual added sugar intake of \<150 kcal/day for men and \<100kcal/day for women;
* No allergies/intolerance to ingredients in the study meal (e.g., nuts, gluten)
Exclusion Criteria
* Abnormal blood chemistry marker that is +/-2.5x the upper or lower limit;
* Chronic clinical diseases (e.g., coronary artery, peripheral artery, or cerebrovascular diseases, diabetes (type 1 and type 2), stages 5-6 chronic kidney disease, chronic obstructive pulmonary disease);
* Major psychiatric disorder (e.g. schizophrenia, bipolar disorder, major depression within past two years);
* Neurological or autoimmune conditions affecting cognition (e.g. Parkinson's disease, epilepsy, multiple sclerosis, head trauma with loss of consciousness greater than 30 min, large vessel infarct);
* Current medication use likely to affect central nervous system functions (e.g. long active benzodiazepines) and lipid-lowering medications (e.g., statins)
* Conditions which would contra-indicate MRI: implant of pacemakers or pacemaker wires; artificial heart valve; brain aneurysm surgery; middle ear implant; non-removable hearing aid or jewelry; braces; cataract surgery or lens implant; implanted mechanical or electrical device; foreign metallic objects in the body such as bullets, BBs, shrapnel, or metalwork fragments, claustrophobia;
* Current smoking;
* Pregnancy or breastfeeding
30 Years
64 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Delaware
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christopher Martens, PhD
Role: STUDY_DIRECTOR
University of Delaware
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Delaware
Newark, Delaware, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1718585
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.